GANGAGEN, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9158
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 8247
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C07K PEPTIDES 2134
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0136,102 PHAGE-DERIVED COMPOSITIONS FOR IMPROVED MYCOBACTERIAL THERAPYMar 26, 15May 18, 17[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9801930 Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expressionFeb 23, 16Oct 31, 17[A61K, C12N, A61P]
9622486 Phage derived antimicrobial activitiesMay 15, 14Apr 18, 17[A61K, A01N, C12N, C07K]
9605250 Chimeric antibacterial polypeptidesApr 12, 12Mar 28, 17[A61K, C12N, C07K]
9289481 Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expressionSep 15, 09Mar 22, 16[A61K, C12N, A61P]
9193946 Reducing conjugative plasmids in bacteriaMar 10, 09Nov 24, 15[C12N]
8748150 Phage derived antimicrobial activitiesMay 21, 12Jun 10, 14[C12N]
8202516 Phage derived antimicrobial activitiesMay 04, 07Jun 19, 12[C12S, A61K, C12N]
7087226 Lysin-deficient bacteriophages having reduced immunogenicityFeb 08, 05Aug 08, 06[A01N]
6913753 Incapacitated whole-cell immunogenic bacterial compositionsSep 27, 02Jul 05, 05[A61K]
6896882 Lysin-deficient bacteriophages having reduced immunogenicitySep 27, 02May 24, 05[A61K, C12Q, A01N, C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0273,585 SOLUBLE CYTOPLASMIC EXPRESSION OF HETEROLOGOUS PROTEINS IN ESCHERICHIA COLIAbandonedApr 11, 13Oct 17, 13[C07K]
2012/0328,576 DEFINED DOSE THERAPEUTIC PHAGEAbandonedJun 29, 12Dec 27, 12[A61K, A61P]
2012/0058,211 DEFINED DOSE THERAPEUTIC PHAGEAbandonedNov 09, 11Mar 08, 12[A61K, A61P]
2007/0020,240 Defined dose therapeutic phageAbandonedOct 06, 04Jan 25, 07[A61K, C12N]
2005/0129,711 Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expressionAbandonedNov 14, 03Jun 16, 05[A61K]
2004/0156,831 Bacteriophage having modified holin and uses thereofAbandonedNov 14, 03Aug 12, 04[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.